MedPath

Does Intravenous Cannabis Reduce Postoperative Nausea and Vomiting (PONV)?

Not Applicable
Terminated
Conditions
Nausea
Vomiting
Interventions
Registration Number
NCT00695487
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
Brief Summary

The investigators evaluate if intravenously applied THC (Cannabis) reduces postoperative Nausea and vomiting. THC will be given during anesthesia before emergence. We measure how long and how effective it reduces PONV

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
320
Inclusion Criteria
  • ASA I-III
  • elective open and laparoscopic surgery >1hour
Exclusion Criteria
  • ambulatory surgery
  • pregnancy, breast feeding
  • >ASA III
  • BMI >35
  • antipsychotic, antiemetic, cytostatic therapy
  • major cardiovascular, renal, hepatic, central nervous system disease
  • current chronic cannabis consumption and hard drug abuse
  • schizophrenia
  • preoperative nausea and vomiting, vestibular disease
  • not speaking german or french
  • refusal to participate

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1THC 9-d-tetra hydro cannabinolReceives 0.125mg/kg THC before emergence
2THC 9-d-tetra hydro cannabinolReceives NaCl before emergence
Primary Outcome Measures
NameTimeMethod
Absence of postoperative Nausea and Vomiting0-24h after Operation
Secondary Outcome Measures
NameTimeMethod
Psychological and physiological data after ingestion of THC Analgetics required0-24h after operation

Trial Locations

Locations (1)

Inselspital, Bern University Hospital

🇨🇭

Bern, Switzerland

© Copyright 2025. All Rights Reserved by MedPath